Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Amortization of Deferred Charges: 2019-2025

Historic Amortization of Deferred Charges for Amphastar Pharmaceuticals (AMPH) over the last 6 years, with Sep 2025 value amounting to $885,000.

  • Amphastar Pharmaceuticals' Amortization of Deferred Charges rose 18.95% to $885,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 60.92%. This contributed to the annual value of $6.0 million for FY2024, which is 47.08% down from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Amortization of Deferred Charges of $885,000 as of Q3 2025, which was up 5.11% from $842,000 recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Amortization of Deferred Charges ranged from a high of $5.2 million in Q3 2023 and a low of -$2.3 million during Q4 2021.
  • Its 3-year average for Amortization of Deferred Charges is $1.8 million, with a median of $885,000 in 2025.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Amortization of Deferred Charges slumped by 334.58% in 2021 and then surged by 9,610.00% in 2023.
  • Amphastar Pharmaceuticals' Amortization of Deferred Charges (Quarterly) stood at -$2.3 million in 2021, then soared by 101.33% to $30,000 in 2022, then spiked by 9,610.00% to $2.9 million in 2023, then slumped by 75.15% to $724,000 in 2024, then climbed by 18.95% to $885,000 in 2025.
  • Its Amortization of Deferred Charges stands at $885,000 for Q3 2025, versus $842,000 for Q2 2025 and $762,000 for Q1 2025.